
| ASSET | DATE | % RETURN |
|---|---|---|
Battalion Oil (BATL) | 2/13/2026 - 3/15/2026 | 575.45% |
Rackspace Technology (RXT) | 2/13/2026 - 3/15/2026 | 355.95% |
Roma Green Finance Limited Ordinary Shares (ROMA) | 2/13/2026 - 3/15/2026 | 162.14% |
Lightwave Logic (LWLG) | 2/13/2026 - 3/15/2026 | 127.84% |
Akso Health Group ADR (AHG) | 2/13/2026 - 3/15/2026 | 81.16% |
Ocugen (OCGN) | 2/13/2026 - 3/15/2026 | 77.14% |
Alto Ingredients (ALTO) | 2/13/2026 - 3/15/2026 | 76.52% |
Verb Technology (VERB) | 2/13/2026 - 3/15/2026 | 72.68% |
Unusual Machines (UMAC) | 2/13/2026 - 3/15/2026 | 72.3% |
Falcon's Beyond Global, Inc Class A Common Stock (FBYD) | 2/13/2026 - 3/15/2026 | 70.85% |
Sabre Corpo (SABR) | 2/13/2026 - 3/15/2026 | 61.11% |
P3 Health Partners (PIII) | 2/13/2026 - 3/15/2026 | 58% |
PRA (PRAA) | 2/13/2026 - 3/15/2026 | 56.36% |
Starfighters Space (FJET) | 2/13/2026 - 3/15/2026 | 54.57% |
Iovance Biotherapeutics (IOVA) | 2/13/2026 - 3/15/2026 | 54.09% |
Lsb Industries (LXU) | 2/13/2026 - 3/15/2026 | 53.03% |
Almonty Industries Inc Common Shares (ALM) | 2/13/2026 - 3/15/2026 | 52.87% |
Shattuck Labs (STTK) | 2/13/2026 - 3/15/2026 | 52.42% |
Relmada Therapeutics (RLMD) | 2/13/2026 - 3/15/2026 | 51.54% |
Sellas Life Sciences (SLS) | 2/13/2026 - 3/15/2026 | 50.84% |
Silence Therapeutics (SLN) | 2/13/2026 - 3/15/2026 | 50.66% |
Palvella Therapeutics (PVLA) | 2/13/2026 - 3/15/2026 | 49.29% |
Pet Acquisition LLC (WOOF) | 2/13/2026 - 3/15/2026 | 48.97% |
Opus Genetics (IRD) | 2/13/2026 - 3/15/2026 | 47.94% |
Allogene Therapeutics (ALLO) | 2/13/2026 - 3/15/2026 | 47.24% |